Jan 29, 2021 | Development / Dossiers
Polypharma has developed a Sodium hyaluronate 0.3% serum. Sodium hyaluronate, as hyaluronic acid, is a natural component of the skin and is used to smooth and tighten the skin, as well as to moisturise it.
Dec 15, 2020 | Development / Dossiers
The technical dossiers for Betamethasone dipropionate 0.05% lotion and Betamethasone dipropionate cream have been completed by Polypharma. This glucocorticoid is used to treat dermatitis, eczema and psoriasis.
Nov 16, 2020 | Development / Dossiers
Polypharma has developed a Terbinafine hydrochloride 1% spray solution for topical application. Terbinafine is an antifungal agent and the most commonly used treatment for skin and foot fungal infections.
Sep 15, 2020 | Development / Dossiers
Polypharma has completed the preparation of a technical dossier for a gel based on 1% diethylamine diclofenac. Diclofenac diethylamine has an analgesic, anti-inflammatory and refreshing effect. It can be used to treat sports injuries, sunburn and arthritis.
Sep 3, 2020 | Development / Dossiers
With this ointment Polypharma is also expanding its portfolio of dermatology products. A product extremely effective for the external treatment of psoriasis. This D3 derivative disrupts the growth and proliferation of keratinocytes and improves the disturbed cell...
Aug 12, 2020 | Development / Dossiers
Polypharma has developed a cream containing the active ingredients fusidic acid and betamethasone. While fusidic acid is known to help with bacterial infections of the skin, betamethasone helps with skin diseases such as psoriasis, neurodermatitis and hives. It is...
